Consolidation for ovarian cancer in remission Journal Article
| Authors: | Sabbatini, P.; Spriggs, D. R. |
| Article Title: | Consolidation for ovarian cancer in remission |
| Keywords: | survival; cancer chemotherapy; treatment outcome; survival analysis; unclassified drug; clinical trial; cisplatin; fluorouracil; cancer growth; note; drug targeting; alpha interferon; paclitaxel; chemotherapy, adjuvant; topotecan; antineoplastic agent; t lymphocyte; ovarian neoplasms; carboplatin; controlled clinical trial; multiple cycle treatment; ovary cancer; breast cancer; randomized controlled trial; antineoplastic combined chemotherapy protocols; membrane proteins; editorial; drug effect; monoclonal antibody; cancer regression; immunology; antibodies, monoclonal; immunotherapy; diagnostic agent; randomized controlled trials; adjuvant chemotherapy; ovary tumor; vaccination; membrane protein; remission; remission induction; clinical research; cell therapy; ca 125 antigen; platinum complex; ca-125 antigen; trastuzumab; cytotoxic t lymphocyte antigen 4; isolation and purification; yttrium; yttrium radioisotopes; yttrium 90; monoclonal antibody hmfg1 yttrium 90; orgovomab; monoclonal antibody hmfg1; muc16 protein, human |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 24 |
| Issue: | 4 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2006-02-01 |
| Start Page: | 537 |
| End Page: | 539 |
| Language: | English |
| DOI: | 10.1200/jco.2005.04.5138 |
| PUBMED: | 16446325 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 14" - "Export Date: 4 June 2012" - "CODEN: JCOND" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
